Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
23
pubmed:dateCreated
1988-12-30
pubmed:abstractText
Three pancreatic beta-cell lines have been established from insulinomas derived from transgenic mice carrying a hybrid insulin-promoted simian virus 40 tumor antigen gene. The beta tumor cell (beta TC) lines maintain the features of differentiated beta cells for about 50 passages in culture. The cells produce both proinsulin I and II and efficiently process each into mature insulin, in a manner comparable to normal beta cells in isolated islets. Electron microscopy reveals typical beta-cell type secretory granules, in which insulin is stored. Insulin secretion is inducible up to 30-fold by glucose, although with a lower threshold for maximal stimulation than that for normal beta cells. beta TC lines can be repeatedly derived from primary beta-cell tumors that heritably arise in the transgenic mice. Thus, targeted expression of an oncogene with a cell-specific regulatory element can be used both to immortalize a rare cell type and to provide a selection for the maintenance of its differentiated phenotype.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-191819, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-2824189, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-2826309, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-2877997, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-2879852, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-2986015, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-3031458, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-3282675, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-3291861, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-3321054, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-3543686, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-3904002, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-3909947, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-4560943, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-6129963, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-6134520, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-6194691, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-6270673, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-6273246, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-6343769, http://linkedlifedata.com/resource/pubmed/commentcorrection/2848253-6375012
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
85
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
9037-41
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene.
pubmed:affiliation
Cold Spring Harbor Laboratory, NY 11724.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't